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Abstract
Background: The use of cell culture for the diagnosis of human metapneumovirus (hMPV) infection is uncommon at 
present and molecular method such as reverse-transcription PCR (RT-PCR) has been widely and most commonly used 
as the preferred test. We aimed to compare the results of virus isolation using Vero E6 cells with real-time RT-PCR for the 
detection of hMPV, since such a comparison data is not available.
Methods: Between December 2007 and July 2008, we obtained 224 nasopharyngeal swab specimens from patients 
with acute respiratory infection and tested by the two methods.
Results: Forty-three (19.2%) were found positive by cell culture and 62 (27.7%) by real-time RT-PCR. Cell cultures were 
positive for 42 of 62 specimens found positive by real-time RT-PCR (67.7% sensitivity) and for 1 of 162 specimens found 
negative by real-time RT-PCR (99.4% specificity), respectively. The sensitivity of the cell culture was 76.2-87.5% (mean 
81.8%) when specimens were collected within 3 days after the onset of symptoms, and the sensitivity decreased to 
50% or less thereafter. Among specimens collected within 3 days after symptom onset, all of the real-time RT-PCR 
positive specimens having a viral load of more than 1.25×105 copies/ml were found positive by cell culture.
Conclusions: Cell culture using Vero E6 cell line has 81.8% sensitivity compared with the real-time RT-PCR method, 
when specimens are collected within 3 days after the onset of symptoms. Thus, this method is a useful method for 
epidemiological and virological research even in facilities with minimal laboratory resources.
Background
Human metapneumovirus (hMPV) was first described in
2001 following its isolation from nasopharyngeal speci-
mens from infants and children with acute respiratory
infection (ARI) in The Netherlands and it has been cate-
gorized as a member of the genus Metapneumovirus of
the subfamily Pneumovirinae of the family Paramyxoviri-
dae [1-3]. It has been recognized as an important agent
responsible for respiratory tract disease worldwide, espe-
cially in the pediatric and elderly populations [2-5], with
serological studies having revealed that hMPV seroposi-
tivity is almost universal by the age of 5 years [3,6].
For laboratory diagnosis, the most definitive test is
virus isolation by cell culture [3]. Although hMPV isola-
tion has commonly been performed using the LLC-MK2
or Vero cell lines, the growth of hMPV is slow and often
requires several blind passages before any cytopathic
effect (CPE) is apparent, particularly following primary
isolation [1,3-5,7,8]. Thus, it is believed that virus isola-
tion is difficult, being possible in only one-third to one-
half of cases in which nasopharyngeal samples are found
to positive for hMPV by reverse-transcription PCR (RT-
PCR) [2,3,5,9]. The use of cell culture for the diagnosis of
hMPV infection is uncommon at present and RT-PCR
has been widely and most commonly used as the pre-
ferred test due to its sensitivity [2,3]. In our previous
study, we demonstrated that the infection efficiency of
hMPV in Vero E6 cells was more than 5 to 20 times better
than that in LLC-MK2 cells and, in fact, we succeeded in
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isolating nearly 100 strains between 2004 and 2006 using
this cell line [6,10,11]. However, there is no data on the
effectiveness of virus isolation in comparison with real-
time RT-PCR for hMPV detection from clinical speci-
mens, since virus isolation is not common. In this paper,
we show the results of virus isolation from 224 clinical
specimens using Vero E6 cells and the real-time RT-PCR
method.
Methods
A total of 224 nasopharyngeal swab specimens were col-
lected from patients who had been clinically diagnosed
with ARI with fever and/or cough and/or rhinorrhea at 3
pediatric clinics in Yamagata and Sendai between
December 2007 and July 2008, as described previously for
the evaluation of a newly developed rapid antigen detec-
tion kit using immunochromatography compared with
real-time RT-PCR [12]. The specimens were collected
and used for the previous and present studies, after get-
ting the informed consent from the patients or their
guardians. These studies were approved by the Institu-
tional Review Board of Sendai Medical Center, National
Hospital Organization Japan, on Feb. 29, 2008 (Reference
No CHI-19-33). Of these specimens, 166 were from chil-
dren aged under 5 years, 43 were from children aged
between 5 and 9 years, 7 were from children aged
between 10 and 15 years and 8 were from patients > 15
years. Each specimen was placed immediately in a tube
containing 3 ml of transport medium [11,12] and trans-
ported at 4°C to the Department of Microbiology,
Yamagata Prefectural Institute of Public Health for virus
isolation and real-time RT-PCR. Prior to specimen inoc-
ulation for virus isolation, 200 μl of the specimen was
transferred to a 1.5 ml microtube and stocked at -80°C
until application to real-time RT-PCR assay. Virus isola-
tion was carried out by the 96-well modified microplate
method including Vero E6 and other five cell lines [10,11].
We observed the plates two or three times per week for
CPEs for 4 weeks without passage or medium change
[10]. When a hMPV-like CPE was observed, second pas-
sage, identification and genotyping was carried out as
described previously [10]. The method and results of
real-time RT-PCR assay with a TaqMan probe using an
ABI Prism 7500 Fast real-time PCR system (Applied Bio-
systems) were described previously [12]. Primers and a
probe targeting the hMPV N gene were designed based
on the reports of Maertzdorf et al. [13] and Bonroy et al.
[14]. Statistical analysis was performed by Fisher's exact
probability test.
Results
As a result, 62 specimens (27.7%) were found positive by
real-time RT-PCR, and 43 (19.2%) by cell culture as
shown in Table 1. One of the 43 cell culture-positive spec-
imen was found negative by real-time RT-PCR. This may
be a false-positive result obtained by cell culture or rather
a false-negative by real-time RT-PCR. On the other hand,
20 of the 62 real-time RT-PCR-positive specimens were
found negative by cell culture. Therefore, the sensitivity
and specificity of cell culture for the detection of hMPV
were 67.7% (42/62) and 99.4% (161/162), respectively,
compared with real-time RT-PCR. The agreement
between the results of cell culture and real-time RT-PCR
was 90.6% (203/224).
Viral loads of the 62 specimens tested positive by real-
time RT-PCR were distributed between 1.99 × 102 and
3.85 ×106. The results of the real-time RT-PCR are shown
in Figure 1. All of the real-time RT-PCR-positive speci-
mens having more than 1.25×105 hMPV copies/ml were
also found positive by cell culture, though two specimens
with 8.79×105 and 1.36×106 copies/ml that were collected
on Day 4 and 5 after the onset of symptoms, respectively,
were negative. The sensitivity of virus isolation for speci-
mens obtained at 1-3 days after the onset of symptoms
was 76.2-87.5% (mean 81.8%), whereas it was less than
25-50% (mean 33.3%) for 4-7 days (Table 1). The sensitiv-
ity of virus isolation for specimens obtained within 3 days
after the onset of symptoms was statistically higher than
that for specimens obtained more than 3 days after the
onset of symptoms (P = .0006).
Discussion
Since the date of specimen collection is important, we
should distinguish the data obtained at 1-3 days after the
onset of symptoms from thereafter, when we compare
virus isolation with real-time RT-PCR method. The sen-
sitivity of virus isolation for specimens during this period
was 76.2-87.5% (mean 81.8%). However, the sensitivity
decreased for specimens collected on Day 4 and thereaf-
ter. This indicates that the excretion of hMPV infectious
particles may decrease after 4 days from the onset of
symptoms, which is in agreement with previous data for
respiratory syncytial virus that indicates the predictive
value of virus isolation is highest when respiratory speci-
mens are collected 1-3 days after the onset of symptoms
[15]. Therefore, specimens for cell culture should be col-
lected within three days after the onset of symptoms. The
merit of real-time RT-PCR over cell culture rests in that it
is able to detect hMPV genome with or without infectiv-
ity during this period. Since the two detection methods
described here differ significantly in cost, turn-around-
time and technical difficulty, we should use each method
depending on the purpose.
Conclusions
Cell culture using Vero E6 cell line has approximately 80%
sensitivity compared with the real-time RT-PCR method
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onset of symptoms. Along with its consistency in not pro-
ducing false-positive results, cell culture using the Vero
E6 cell line to be regarded as a useful method for epide-
miological and virological research, through not for rap-
i d l y  c l i n i c a l  d i a g n o s i s .  F u r t h e r m o r e ,  t h i s  c e l l  c u l t u r e
method might be applicable in facilities with minimal lab-
oratory resources without expensive real-time RT-PCR
system.
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Table 1: Comparison of virus isolation with real-time RT-PCR in hMPV detection
Days of specimen collection 
after onset of illness
No. of 
specimens
No. of specimens with the following resultsa: Sensitivity Specificity
P+,C+ P+,C- P-,C+ P-,C- (%) (%)
1 48 13 2 0 33 86.7 100
2 77 16 5 0 56 76.2 100
3 38 7 1 0 30 87.5 100
4 25 3 3 1 18 50 94.7
> 4 36 3 9 0 24 25 100
1-7 224 42 20 1 161 67.7 99.4
aAbbreviations; P, real-time RT-PCR; C, cell culture
Figure 1 Viral loads of real-time RT-PCR-positive specimens and 
the number of days from onset of fever to specimen collection. 
Solid triangles indicate the 62 specimens that tested positive for hMPV 
by real-time RT-PCR assay. Specimens testing negative by cell culture 
are marked with daggers.Matsuzaki et al. BMC Infectious Diseases 2010, 10:170
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